Bio-Techne Corporation
TECH
주식 순위
#1871
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
주가
$72.49
시가총액
$11.37B
변동 (1일)
-0.12%
변동 (1년)
17.18%
국가
US
거래 Bio-Techne Corporation (TECH)
카테고리
Healthcare
Bio-Techne Corporation (TECH)의 매출
Jun 2026 기준 매출 TTM: $1.22B
Bio-Techne Corporation의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $1.22B입니다. 2024년에 회사는 $1.16B의 수익을 올렸으며 이는 2023년의 $1.14B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Bio-Techne Corporation의 수익 기록 (2000 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $1.22B | -0.38% |
| 2025 | $1.22B | 5.23% |
| 2024 | $1.16B | 1.97% |
| 2023 | $1.14B | 2.81% |
| 2022 | $1.11B | 18.75% |
| 2021 | $931.03M | 26.04% |
| 2020 | $738.69M | 3.46% |
| 2019 | $714.01M | 11.04% |
| 2018 | $642.99M | 14.21% |
| 2017 | $563.00M | 12.82% |
| 2016 | $499.02M | 10.34% |
| 2015 | $452.25M | 26.41% |
| 2014 | $357.76M | 15.19% |
| 2013 | $310.58M | -1.27% |
| 2012 | $314.56M | 8.48% |
| 2011 | $289.96M | 7.77% |
| 2010 | $269.05M | 1.93% |
| 2009 | $263.96M | 2.54% |
| 2008 | $257.42M | 15.19% |
| 2007 | $223.48M | 10.30% |
| 2006 | $202.62M | 13.41% |
| 2005 | $178.65M | 10.79% |
| 2004 | $161.26M | 11.20% |
| 2003 | $145.01M | 10.78% |
| 2002 | $130.90M | 13.47% |
| 2001 | $115.36M | 11.09% |
| 2000 | $103.84M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $12.62B | 939.00% |
US
|
|
| $2.23B | 83.37% |
US
|
|
| $15.74B | 1,195.79% |
AU
|
|
| - | - |
CH
|
|
| $6.02B | 395.56% |
NL
|
